Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

Ian D Hay, I. Ross McDougall, James C. Sisson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

Original languageEnglish (US)
Pages (from-to)1395-1397
Number of pages3
JournalJournal of Nuclear Medicine
Volume49
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Thyroid Neoplasms
Therapeutics

Keywords

  • Ablation
  • Endocrinology
  • Oncology
  • Radioiodine
  • Radionuclide therapy
  • Thyroid carcinoma

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Perspective : The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma. / Hay, Ian D; McDougall, I. Ross; Sisson, James C.

In: Journal of Nuclear Medicine, Vol. 49, No. 8, 01.08.2008, p. 1395-1397.

Research output: Contribution to journalArticle

@article{761f10b1cd994b958b37d19cf032dba0,
title = "Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma",
abstract = "We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.",
keywords = "Ablation, Endocrinology, Oncology, Radioiodine, Radionuclide therapy, Thyroid carcinoma",
author = "Hay, {Ian D} and McDougall, {I. Ross} and Sisson, {James C.}",
year = "2008",
month = "8",
day = "1",
doi = "10.2967/jnumed.108.052654",
language = "English (US)",
volume = "49",
pages = "1395--1397",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "8",

}

TY - JOUR

T1 - Perspective

T2 - The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

AU - Hay, Ian D

AU - McDougall, I. Ross

AU - Sisson, James C.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

AB - We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

KW - Ablation

KW - Endocrinology

KW - Oncology

KW - Radioiodine

KW - Radionuclide therapy

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=48749128137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749128137&partnerID=8YFLogxK

U2 - 10.2967/jnumed.108.052654

DO - 10.2967/jnumed.108.052654

M3 - Article

AN - SCOPUS:48749128137

VL - 49

SP - 1395

EP - 1397

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 8

ER -